Martin John Shott
Chairman at European Pharmaceuticals Group Ltd.
Profile
Martin John Shott is currently the Chairman at European Pharmaceuticals Group Ltd.
and a Member at Royal Pharmaceutical Society of Great Britain.
He previously worked as the Director-Pharmaceutical Operations at Vectura Group Ltd., Associate Director-Research & Development at Innovata Biomed Ltd., Senior Manager at Novartis AG, and Senior Manager at Lers-Synthelabo.
Dr. Shott holds a doctorate degree from The University of Nottingham.
Martin John Shott active positions
| Companies | Position | Start |
|---|---|---|
European Pharmaceuticals Group Ltd.
 European Pharmaceuticals Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Cardinal Health, Inc., European Pharmaceuticals Group Ltd. is a holding British company with investments in subsidiary undertakings engaged in pharmaceuticals. The company is based in Romford, UK. European Pharmaceuticals Group was acquired by The Intercare Group Plc from Groenwondt Beheer Bv on September 17, 1999 for $40.03 million. | Chairman | 14/09/2010 |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | 14/09/2010 |
Former positions of Martin John Shott
| Companies | Position | End |
|---|---|---|
| Lers-Synthelabo | Corporate Officer/Principal | - |
Innovata Biomed Ltd.
 Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Innovata Biomed Ltd. engages in the research, development, and commercialization of respiratory drug delivery technologies. The company is based in Edinburgh, UK. | Chief Tech/Sci/R&D Officer | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
| VECTURA GROUP | Chief Operating Officer | 24/11/2011 |
Training of Martin John Shott
| The University of Nottingham | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private companies | 5 |
|---|---|
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Innovata Biomed Ltd.
Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Innovata Biomed Ltd. engages in the research, development, and commercialization of respiratory drug delivery technologies. The company is based in Edinburgh, UK. | Commercial Services |
European Pharmaceuticals Group Ltd.
European Pharmaceuticals Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Cardinal Health, Inc., European Pharmaceuticals Group Ltd. is a holding British company with investments in subsidiary undertakings engaged in pharmaceuticals. The company is based in Romford, UK. European Pharmaceuticals Group was acquired by The Intercare Group Plc from Groenwondt Beheer Bv on September 17, 1999 for $40.03 million. | Health Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
| Lers-Synthelabo |
- Stock Market
- Insiders
- Martin John Shott
